200
Participants
Start Date
February 3, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Somapacitan
Sogroya® therapy in participants with AGHD (only severe case) under normal clinical practice conditions
Ikeda Hospital, Diabetes Medicine, Amagasaki-shi, Hyogo
University of Yamanashi Hospital, Chuo-shi, Yamanashi-ken
Fukuoka University Chikushi Hospital_Endocrinology and Diabetes Mellitus, Fukuoka
Kurume University Hospital, Fukuoka
Fukuoka University Hospital, Fukuoka-shi, Fukuoka-ken
Kyushu University Hospital, Fukuoka-shi, Fukuoka
Gifu University Hospital, Gifu
Tsugaru General Hospital, Goshogawara-shi, Aomori-ken
Gunma University Hospital, Dept. of Endocrinology and Diabetes, Gunma
Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka
Hirosaki University Hospital, Hirosaki-shi, Aomori-ken
Hyogo Prefectural Kakogawa Medical Center, Hyōgo
Takara Clinic, Iida-shi, Nagano-ken
Shimane Univ. HP, Dept of Endocrinology&Metabolism, Izumo, Shimane
Joetsu General Hospital, Joetsu-shi, Niigata-ken
Kagoshima Medical Center, Kagoshima-shi, Kagoshima-ken
Kagoshima University Hospital_Neurosurgery, Kagoshima-shi, Kagoshima
Yokohama Medical Center, Kanagawa
Kitasato University Hospital, Kanagawa
Nara Medical University Hospital_Kashihara-shi, Nara, Kashihara-shi, Nara
Nippon Medical School Musashikosugi Hospital_Neurological Surgery, Kawasaki-shi, Kanagawa
Kobe University Hospital, Kobe-shi, Hyogo
Konan Hospital, Kumamoto
Kumamoto University Hospital, Diabetes, Metabo and Endo, Kumamoto-shi, Kumamoto
Kyoto University Hospital, Kyoto-shi, Kyoto
Toranomon Hospital, Endocrinology and Metabolism, Minato-ku, Tokyo
University of Miyazaki Hospital, Miyazaki-shi, Miyazaki-ken
Aichi Medical University Hospital, Nagakute-shi, Aichi
Okamoto Internal Medicine and Pediatrics Clinic, Nara
Kurebayashi Diabetes Clinic, Nishinomiya-shi, Hyogo-ken
Okayama University Hospital_General Medicine, Okayama-shi, Okayama
Osaka Endocrine Clinic, Osaka
Kibounomori Clinic, Osaka
Osaka City University Hospital, Osaka
Yasuhara Children's Clinic, Osaka
Osaka Women's and Children's Hospital, Osaka
NTT East Japan Sapporo HP, Diabetes Mellitus & Int med Endo, Sapporo, Hokkaido
JCHO Sendai Hospital, Sendai-shi, Miyagi-ken
Omi Medical Center, Shiga
Hamamatsu-kita-Hospital, Shizuoka
Hamamatsu Medical Center, Shizuoka
Shizuoka General Hospital, Shizuoka-shi, Shizuoka-ken
Tochigi Medical Center Shimotsuga, Tochigi-shi, Tochigi-ken
Hosaka Kodomo Clinic, Tokyo
Ehime University Hospital, Toon-shi, Ehime
Tottori University Hospital_Endocrinology and Metabolism, Tottori
Yamagata University Hospital, Internal Medicine 3, Yamagata-shi, Yamagata
Lead Sponsor
Novo Nordisk A/S
INDUSTRY